ClinicalTrials.Veeva

Menu

Lactobacillus Reuteri Versus Herbal Drop in the Treatment of Infantile Colic: a Prospective Study

D

Dr. Sami Ulus Children's Hospital

Status

Completed

Conditions

Crying

Treatments

Dietary Supplement: placebo sterile water
Dietary Supplement: Herbal drop
Dietary Supplement: Lactobacillus reuteri

Study type

Interventional

Funder types

Other

Identifiers

NCT01855269
134/Feb 2012

Details and patient eligibility

About

The aim was to test the hypothesis that oral administration of Lactobacillus reuteri in a prospective randomized controlled study would improve symptoms of infantile colic.

Full description

Infantile colic ıs one of the most common problems within the first 3 months of life, affecting as many as 3% to 28% of newborn children. It consists of a behavioral syndrome characterized by paroxysmal, excessive, inconsolable crying without identifiable cause. Lactobacillus reuteri, one of the few endogenous lactobacillus species in the human gastrointestinal tract, has been used safely for many years as a probiotic dietary supplement in adults, and recent data demonstrated safety after long-term dietary supplementation for newborn infants. The positive effects of this probiotic on intestinal disorders such as constipation and diarrhea and in protection from infection,as well as its capacity to modulate immune responses.

The aim was to test the hypothesis that oral administration of Lactobacillus reuteri in a prospective randomized controlled study would improve symptoms of infantile colic.

Enrollment

74 patients

Sex

All

Ages

3 weeks to 3 months old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • infants three weeks to three months
  • infants with colic three hours of crying on three days in the week
  • infants feeding with breast milk
  • infants weighing 2500 to 4000 gram

Exclusion criteria

  • chronic illness
  • gastrointestinal disorders
  • infants received either antibiotics or probiotics in the previous week

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

74 participants in 3 patient groups, including a placebo group

Lactobacillus reuteri
Active Comparator group
Description:
Lactobacillus reuteri (BioGaia, Stockholm, Sweden):at a dose of 100 million colony forming unit in 5 drops, 30 minutes after feeding, once per day for 3 weeks
Treatment:
Dietary Supplement: Lactobacillus reuteri
Herbal drop
Active Comparator group
Description:
Herbal drop containing sodium bicarbonate, Pimpinella anisum oil, foeniculum vulgare oil, Mentha piperita (Babs, Berko, Istanbul, Turkey):5 drops 30 minutes after feeding, once per day for 3 weeks
Treatment:
Dietary Supplement: Herbal drop
Sterile water
Placebo Comparator group
Description:
Sterile water: 5 drops, 30 minutes after feeding, once per day for 3 weeks
Treatment:
Dietary Supplement: placebo sterile water

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems